ONC
$386.49+0.52%
as of close, Oct 21, 2026
☾ AH $386.49 +0.52%
BeOne Medicines Ltd. American Depositary SharesStock · Healthcare
ONC — BeOne Medicines Ltd. American Depositary Shares price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeEEEEEEEEEEEEE
50.0100.0150.0200.0250.0300.0350.005.0M$386.49—20162019202120242026
2026-10-21
Price$386.49
MA20$326.48
MA50$324.33
Vol2.4M
Key stats#
Price data
- Price
- $386.49
- YTD price return
- +27.21%
- YTD total return
- +27.21%
- Next earnings
- Nov 5, 2026
- Market cap
- 43.9B
- Enterprise value
- 40B
- Shares outstanding
- 113.7M
- 52W low
- $253.95
- 52W high
- $388.66
- From 52W high
- -0.56%
- From 52W low
- +52.19%
- 52W range
- 98%
- Beta
- 0.50
Volume
- Rel volume
- 1.31×
- 30D volume
- 398.1K
- 30D $ vol
- 143.5M
Insider trading
- Insider net 1W
- none
- Insider net 1M
- −$22.6M
- Insider net 3M
- −$124.3M
- Insider net 1Y
- −$340.6M
Form 4 transactions by trade date, as filed; latest on file 2026-10-13.
Fundamentals
- Sales (ttm)
- 6.1B
- Sales/share
- $53.90
- EPS (ttm)
- $5.68
- FCF (ttm)
- 1.3B
- FCF/share
- $11.70
- Book value/share
- $45.50
- Net margin
- 10.70%
- ROE
- 12.67%
- ROA
- 7.15%
- Debt / equity
- 0.17×
- Current ratio
- 3.40
Growth (CAGR, ttm) · 10Y
- Sales
- +34.38%+50.13%+45.29%+96.56%
- FCF
- +443.92%n/an/an/a
- Shares
- +3.34%+2.41%+4.07%+13.20%
Per-share growth (CAGR, ttm) · 10Y
- Sales/share
- +30.03%+46.60%+39.61%+73.64%
- FCF/share
- +426.33%n/an/an/a
- Book value/share
- +32.82%+8.24%+3.28%+21.15%
- Price
- +22.43%+32.71%+0.59%+27.90%
- Total return
- +22.43%+32.71%+0.59%+27.90%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 68.0×
- Fwd P/E
- 36.5×
- P/S (ttm)
- 7.2×
- P/B (mrq)
- 8.5×
- P/FCF (ttm)
- 33.0×
- EV/EBITDA (fy)
- 37.1×
- EV/Sales (ttm)
- 6.5×
- FCF yield (ttm)
- 3.03%
- Buyback yield (realized, 1y)
- -3.34%
- Shareholder yield (realized, 1y)
- -3.34%
- Buyback yield (cash, ttm)
- 0.00%
- Shareholder yield (cash, ttm)
- 0.00%
Vs own 10Y history
- P/S
- 23rd
- P/B
- 82nd
Bar = where today’s multiple sits in ONC’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-21#
1D
+0.52%
5D
+9.96%
1M
+5.69%
3M
+21.28%
YTD
+27.21%
1Y
+22.41%
5Y
+2.99%
Recent filings#
- Sep 1Insider sale · Ball Titus B. (Principal Accounting Officer) sold 132 ADS shares for $47K at $355.86
- Aug 268-K · Results of operations
- Aug 5Earnings · Earnings release — EPS $2.05 vs $1.40 est. (+46.4%); revenue $1.71B (+30% y/y) 1.4%
- Aug 3Insider sale · Rosenberg Aaron (Chief Financial Officer) sold 1,157 ADS shares for $362K at $312.72
- Jul 30Insider sale · Lee Chan Henry (SVP, General Counsel) sold 1,044 ADS shares for $338K at $323.69
Financial statements
Open full ONC financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +9.21% | -0.89% |
| JNJ | Johnson & Johnson | -4.39% | -0.66% |
| ABBV | AbbVie Inc. | +7.65% | -1.51% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +10.44% | -0.55% |
| MRK | Merck & Co. Inc. | +0.26% | +1.07% |
| NVS | Novartis AG | +9.19% | +0.20% |
| TMO | Thermo Fisher Scientific Inc. | +5.43% | +1.04% |
| AMGN | Amgen Inc. | +11.46% | -0.17% |
